Leilani Morales

Company: Roche

Job title: Head, Medical Development and Evidence Generation

Seminars:

Understanding Safety Regulations to Stay Ahead of Possible Impacts on Development of Additional GLP-1-Based Therapeutics 11:30 am

Reaffirming confidence in the safety of GLP-1 treatments to weigh up the possibility of further regulation on development of GLP-1 therapies Considering the concerns of the European Medicine Agency (EMA) regarding the mental health side effects of GLP-1s to weigh up possible risks Reflecting on how regulation could create new challenges in GLP-1 development and…Read more

day: Conference Day Two